These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 23532213)

  • 21. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine.
    Agusti A; Sobradillo P; Celli B
    Am J Respir Crit Care Med; 2011 May; 183(9):1129-37. PubMed ID: 21169466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future perspectives of personalized oncology.
    Stambuk S; Sundov D; Kuret S; Beljan R; Andelinović S
    Coll Antropol; 2010 Jun; 34(2):763-9. PubMed ID: 20698168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future.
    Buriani A; Garcia-Bermejo ML; Bosisio E; Xu Q; Li H; Dong X; Simmonds MS; Carrara M; Tejedor N; Lucio-Cazana J; Hylands PJ
    J Ethnopharmacol; 2012 Apr; 140(3):535-44. PubMed ID: 22342380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological markers in haematological malignancies.
    Lemal R; Tournilhac O; Bay JO
    Bull Cancer; 2014 Jun; 101 Suppl 1():S7-11. PubMed ID: 24966076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microarrays: Molecular allergology and nanotechnology for personalised medicine (II).
    Lucas JM
    Allergol Immunopathol (Madr); 2010; 38(4):217-23. PubMed ID: 20537785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoinformatics and systems biology methods for personalized medicine.
    Yan Q
    Methods Mol Biol; 2010; 662():203-20. PubMed ID: 20824473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Personalized medicine in haematooncology--the pathologist's perspective].
    Campr V
    Cas Lek Cesk; 2010; 149(10):464-7. PubMed ID: 21121135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systems medicine and metabolic modelling.
    Mardinoglu A; Nielsen J
    J Intern Med; 2012 Feb; 271(2):142-54. PubMed ID: 22142312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-testis antigens in haematological malignancies.
    Meklat F; Li Z; Wang Z; Zhang Y; Zhang J; Jewell A; Lim SH
    Br J Haematol; 2007 Mar; 136(6):769-76. PubMed ID: 17223912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1925-33. PubMed ID: 23242718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Proteomics techniques and their application in haemato-oncologic malignancies].
    Zelená J; Hájek R
    Cas Lek Cesk; 2007; 146(7):586-92. PubMed ID: 17722845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A challenging drug development process in the era of personalized medicine.
    Jørgensen JT
    Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An experience with sixty cases of haematological malignancies; a clinico haematological correlation.
    Idris M; Shah SH; Fareed J; Gul N
    J Ayub Med Coll Abbottabad; 2004; 16(4):51-4. PubMed ID: 15762065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human tissue in systems medicine.
    Caie PD; Schuur K; Oniscu A; Mullen P; Reynolds PA; Harrison DJ
    FEBS J; 2013 Dec; 280(23):5949-56. PubMed ID: 24118991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine.
    van der Greef J; van Wietmarschen H; Schroën J; Wang M; Hankemeier T; Xu G
    Planta Med; 2010 Dec; 76(17):2036-47. PubMed ID: 20979015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century.
    Schnackenberg LK
    Expert Rev Mol Diagn; 2007 May; 7(3):247-59. PubMed ID: 17489732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.